Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$3.12M Sell
43,010
-410
-0.9% -$27.6K 1.53% 18
2017
Q1
$2.83M Buy
43,420
+3,625
+9% +$228K 1.45% 17
2016
Q4
$2.49M Buy
39,795
+175
+0.4% +$10.7K 1.41% 20
2016
Q3
$2.5M Buy
39,620
+800
+2% +$51.8K 1.48% 20
2016
Q2
$2.4M Buy
38,820
+1,205
+3% +$73.4K 1.54% 19
2016
Q1
$2.15M Buy
37,615
+1,310
+4% +$73K 1.45% 19
2015
Q4
$2.15M Buy
36,305
+11,130
+44% +$641K 1.57% 18
2015
Q3
$1.37M Buy
25,175
+800
+3% +$52.1K 1.04% 26
2015
Q2
$1.64M Buy
24,375
+3,675
+18% +$240K 1.12% 27
2015
Q1
$1.21M Buy
20,700
+4,300
+26% +$260K 0.83% 31
2014
Q4
$1.07M Buy
16,400
+300
+2% +$18.9K 0.91% 33
2014
Q3
$930K Sell
16,100
-300
-2% -$16.7K 0.83% 34
2014
Q2
$926K Buy
16,400
+185
+1% +$9.71K 0.8% 35
2014
Q1
$833K Buy
16,215
+100
+0.6% +$5.05K 0.74% 37
2013
Q4
$851K Buy
16,115
+40
+0.2% +$1.97K 0.74% 34
2013
Q3
$719K Sell
16,075
-800
-5% -$35.5K 0.69% 36
2013
Q2
$698K Buy
+16,875
New +$738K 0.7% 40

Other funds holding ABBV

iAB Financial Bank's ABBV Position: Q2 2017 in Review

iAB Financial Bank reduced its AbbVie (ABBV) stake by 0.94% in Q2 2017, selling an estimated $27.6K and leaving 43,010 shares worth $3.12M. The position accounts for 1.53% of the portfolio, ranked #18.

iAB Financial Bank first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • iAB Financial Bank held 43,010 shares of AbbVie worth $3.12M as of Q2 2017.
  • iAB Financial Bank sold 410 AbbVie shares in Q2 2017, an estimated $27.6K.
  • AbbVie made up 1.53% of iAB Financial Bank's portfolio in Q2 2017, its #18 holding.
  • iAB Financial Bank first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on iAB Financial Bank's 13F filing for Q2 2017, filed 4 Aug 2017.